Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: MELANOMA - IMMUNOLOGY , . Treffer: 55

2016

Garg, K; Maurer, M; Griss, J; Brüggen, MC; Wolf, IH; Wagner, C; Willi, N; Mertz, KD; Wagner, SN Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
Hum Pathol. 2016; 54(6):157-164
Web of Science PubMed FullText FullText_MUG

 

Richtig, E; Trapp, M; Kapfhammer, HP; Jenull, B; Richtig, G; Trapp, EM The Importance of a Biopsychosocial Approach in Melanoma ResearchExperiences from a Single-center Multidisciplinary Melanoma Working Group in Middle-Europe.
Acta Derm Venereol. 2016; 96(217):51-54 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Trapp, EM; Trapp, M; Avian, A; Rohrer, PM; Weissenböck, T; Kapfhammer, HP; Demel, U; Linder, MD; Kresse, A; Richtig, E Association of Stress Coping Strategies with Immunological Parameters in Melanoma Patients.
Acta Derm Venereol. 2016; 96(217):74-77 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Køllgaard, T; Ugurel-Becker, S; Idorn, M; Andersen, MH; Becker, JC; Straten, PT Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide Epitopes.
PLoS One. 2015; 10(7):e0131934-e0131934 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Richtig, E; Trapp, EM; Avian, A; Brezinsek, HP; Trapp, M; Egger, JW; Kapfhammer, HP; Rohrer, PM; Berghold, A; Curiel-Lewandrowski, C; Demel, U Psychological Stress and Immunological Modulations in Early-stage Melanoma Patients.
Acta Derm Venereol. 2015; 95(6):691-695 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Oliveira, A; Arzberger, E; Massone, C; Fink-Puches, R; Zalaudek, I; Hofmann-Wellenhof, R Dermoscopy, reflectance confocal microscopy and immunohistochemical analysis in melanocytic lesions with Meyerson's phenomenon.
Dermatology. 2014; 229(4):297-305 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Weide, B; Eigentler, TK; Pflugfelder, A; Zelba, H; Martens, A; Pawelec, G; Giovannoni, L; Ruffini, PA; Elia, G; Neri, D; Gutzmer, R; Becker, JC; Garbe, C Intralesional treatment of stage III metastatic melanoma patients with L19-IL2 results in sustained clinical and systemic immunologic responses.
Cancer Immunol Res. 2014; 2(7):668-678 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Kruit, WH; Suciu, S; Dreno, B; Mortier, L; Robert, C; Chiarion-Sileni, V; Maio, M; Testori, A; Dorval, T; Grob, JJ; Becker, JC; Spatz, A; Eggermont, AM; Louahed, J; Lehmann, FF; Brichard, VG; Keilholz, U Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma.
J Clin Oncol. 2013; 31(19): 2413-2420. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2012

Becker, JC; Andersen, MH; Hofmeister-Muller, V; Wobser, M; Frey, L; Sandig, C; Walter, S; Singh-Jasuja, H; Kampgen, E; Opitz, A; Zapatka, M; Brocker, EB; Straten, PT; Schrama, D; Ugurel, S; Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma.
Cancer Immunol Immunother. 2012; 61(11):2091-2103 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2009

Hofmann, UB; Voigt, H; Andersen, MH; Straten, PT; Becker, JC; Eggert, AO Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes.
Eur J Immunol. 2009; 39(5):1419-1424
Web of Science PubMed FullText FullText_MUG

 

Hofmeister-Mueller, V; Vetter-Kauczok, CS; Ullrich, R; Meder, K; Lukanidin, E; Broecker, EB; Straten, PT; Andersen, MH; Schrama, D; Becker, JC Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients.
Cancer Immunol Immunother. 2009; 58(8):1265-1273
Web of Science PubMed FullText FullText_MUG

 

Sorensen, RB; Junker, N; Kirkin, A; Voigt, H; Svane, IM; Becker, JC; Straten, PT; Andersen, MH The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines.
Cancer Immunol Immunother. 2009; 58(5):665-675
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Straten, PT; Becker, JC Adoptive cell transfer in the treatment of metastatic melanoma.
J Invest Dermatol. 2009; 129(12):2743-2745 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2008

Houben, R; Wischhusen, J; Menaa, F; Synwoldt, P; Schrama, D; Brocker, EB; Becker, JC Melanoma stem cells: targets for successful Therapy?
J DTSCH DERMATOL GES. 2008; 6(7): 541-547.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Schrama, D; Hauschild, A; Becker, JC Immunmodulatory antibodies in the treatment of skin cancer
Hautarzt. 2008; 59(10):806-813
Web of Science PubMed FullText FullText_MUG

 

2007

Wobser, M; Voigt, H; Houben, R; Eggert, AO; Freiwald, M; Kaemmerer, U; Kaempgen, E; Schrama, D; Becker, JC Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression.
Cancer Immunol Immunother. 2007; 56(7):1017-1024
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2006

Dejaco, C; Duftner, C; Schirmer, M Induction of tolerance in autoimmune diseases rather than cure of cancer by interleukin-2 therapy.
J Clin Oncol. 2006; 24(20): e34; author reply e35-e34; author reply e36. [OPEN ACCESS]
PubMed FullText FullText_MUG

 

Fensterle, J; Trefzer, U; Berger, T; Andersen, MH; Ugurel, S; Becker, JC HLA-B8 association with late-stage melanoma - an immunological lesson?
BMC MED. 2006; 4: [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Müller-Berghaus, J; Ehlert, K; Ugurel, S; Umansky, V; Bucur, M; Schirrmacher, V; Beckhove, P; Schadendorf, D Melanoma-reactive T cells in the bone marrow of melanoma patients: association with disease stage and disease duration.
Cancer Res. 2006; 66(12):5997-6001 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Pashenkov, M; Goëss, G; Wagner, C; Hörmann, M; Jandl, T; Moser, A; Britten, CM; Smolle, J; Koller, S; Mauch, C; Tantcheva-Poor, I; Grabbe, S; Loquai, C; Esser, S; Franckson, T; Schneeberger, A; Haarmann, C; Krieg, AM; Stingl, G; Wagner, SN Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma.
J CLIN ONCOL. 2006; 24(36): 5716-5724. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schrama, D; Terheyden, P; Otto, K; Kammerer, U; Brocker, EB; Luhder, F; Cosman, D; Andersen, MH; Becker, JC Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cells.
Eur J Immunol. 2006; 36(1):65-72
Web of Science PubMed FullText FullText_MUG

 

Straten, PT; Dahl, C; Schrama, D; Pedersen, LO; Andersen, MH; Seremet, T; Brocker, EB; Guldberg, P; Becker, JC Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes.
Cancer Immunol Immunother. 2006; 55(5):495-502
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Voigt, H; Schrama, D; Eggert, AO; Vetter, CS; Muller-Blech, K; Reichardt, HM; Andersen, MH; Becker, JC; Luhder, F CD28-mediated costimulation impacts on the differentiation of DC vaccination-induced T cell responses.
Clin Exp Immunol. 2006; 143(1):93-102 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2005

Andersen, MH; Reker, S; Kvistborg, P; Becker, JC; Straten, PT Spontaneous immunity against Bcl-xL in cancer patients.
J Immunol. 2005; 175(4):2709-2714 [OPEN ACCESS]
Web of Science PubMed

 

Andersen, MH; Reker, S; Stratem, PT; Gehl, J; Geertsen, P; Becker, JC Concomitant administration of interleukin-2 during therapeutic vaccinations against cancer: the good, the bad, or the evil?
J Clin Oncol. 2005; 23(22):5265-5267 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Becker, JC; Straten, PT; Andersen, MH The paradoxical association between Bcl-2 expression and prognosis: does the immune system make the difference?
Cancer Res. 2005; 65(7):2983-2983 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2004

Andersen, MH; Fensterle, J; Ugurel, S; Reker, S; Houben, R; Guldberg, P; Berger, TG; Schadendorf, D; Trefzer, U; Brocker, EB; Straten, PT; Rapp, UR; Becker, JC Immunogenicity of constitutively active (V599E)BRaf
CANCER RES. 2004; 64(15): 5456-5460. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Berger, TG; Haendle, I; Schrama, D; Luftl, M; Bauer, N; Pedersen, LO; Schuler-Thurner, B; Hohenberger, W; Straten, PT; Schuler, G; Becker, JC Circulation and homing of melanoma-reactive T cells to both cutaneous and visceral metastases after vaccination with monocyte-derived dendritic cells
INT J CANCER. 2004; 111(2): 229-237. (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Ugurel, S; Uhlig, D; Pföhler, C; Tilgen, W; Schadendorf, D; Reinhold, U Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients.
Cancer Immunol Immunother. 2004; 53(6):551-559
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2003

Andersen, MH; Gehl, J; Reker, S; Pedersen, LO; Becker, JC; Geertsen, P; Straten, PT Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration.
Semin Cancer Biol. 2003; 13(6):449-459
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Schrama, D; Eggert, AAO; Brocker, EB; Pedersen, LO; Straten, PT; Becker, JC Immunological consequences of the sentinel lymph-node biopsy - lessons from a melanoma patient
LANCET ONCOL. 2003; 4(7): 446-447. (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Terheyden, P; Schrama, D; Pedersen, LO; Andersen, MH; Kampgen, E; Straten, PT; Becker, JC Longitudinal analysis of MART-1/HLA-A2-reactive T cells over the course of melanoma progression
SCAND J IMMUNOL. 2003; 58(5): 566-571.
Web of Science PubMed FullText FullText_MUG

 

Ugurel, S; Schadendorf, D Systemic treatment in advanced melanoma: innovative perspectives.
Onkologie. 2003; 26(3):234-238
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2002

Pedersen, LO; Vetter, CS; Mingari, MC; Andersen, MH; Straten, PT; Brocker, EB; Becker, JC Differential expression of inhibitory or activating CD94/NKG2 subtypes on MART-1-reactive T cells in vitiligo versus melanoma: a case report.
J Invest Dermatol. 2002; 118(4):595-599 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Schrama, D; Fuchs, E; Brocker, EB; Straten, PT; Becker, JC Identical T-cell receptor transcripts in multiple melanoma metastases.
Cancer Res. 2002; 62(20):5664-5667 [OPEN ACCESS]
Web of Science PubMed FullText

 

Schrama, D; Pedersen, LO; Keikavoussi, P; Andersen, MH; Straten, PT; Brocker, EB; Kampgen, E; Becker, JC Aggregation of antigen-specific T cells at the inoculation site of mature dendritic cells.
J Invest Dermatol. 2002; 119(6):1443-1448 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Ugurel, S; Reinhold, U; Tilgen, W HLA-G in melanoma: A new strategy to escape from immunosurveillance?
Onkologie. 2002; 25(2):129-134
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Vetter, CS; Groh, V; Straten, PT; Spies, T; Brocker, EB; Becker, JC Expression of stress-induced MHC class I related chain molecules on human melanoma.
J Invest Dermatol. 2002; 118(4):600-605 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2001

Schrama, D; Andersen, MH; Terheyden, P; Schroder, L; Pedersen, LO; Straten, PT; Becker, JC Oligoclonal T-cell receptor usage of melanocyte differentiation antigen-reactive T cells in stage IV melanoma patients
CANCER RES. 2001; 61(2): 493-496. [OPEN ACCESS]
Web of Science PubMed FullText

 

Ugurel, S; Rebmann, V; Ferrone, S; Tilgen, W; Grosse-Wilde, H; Reinhold, U Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy.
Cancer. 2001; 92(2):369-376
Web of Science PubMed FullText FullText_MUG

 

2000

Becker, JC; Straten, PT T-cell clonality in immune responses.
Immunol Today. 2000; 21(2):107-107
Web of Science PubMed Google Scholar

 

Becker, JC; Vetter, CS; Schrama, D; Brocker, EB; Straten, PT Differential expression of CD28 and CD94/NKG2 on T cells with identical TCR beta variable regions in primary melanoma and sentinel lymph node
EUR J IMMUNOL. 2000; 30(12): 3699-3706.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Terheyden, P; Straten, PT; Brocker, EB; Kampgen, E; Becker, JC CD40-ligated dendritic cells effectively expand melanoma-specific CD8+ CTLs and CD4+ IFN-gamma-producing T cells from tumor-infiltrating lymphocytes.
J Immunol. 2000; 164(12):6633-6639 [OPEN ACCESS]
Web of Science PubMed Google Scholar

 

1999

Straten, PT; Becker, JC; Guldberg, P; Zeuthen, J In situ T cells in melanoma.
Cancer Immunol Immunother. 1999; 48(7):386-395
Web of Science PubMed

 

Straten, PT; Guldberg, P; Gronbaek, K; Hansen, MR; Kirkin, AF; Seremet, T; Zeuthen, J; Becker, JC In situ T cell responses against melanoma comprise high numbers of locally expanded T cell clonotypes.
J Immunol. 1999; 163(1):443-447 [OPEN ACCESS]
Web of Science PubMed Google Scholar

 

1998

Lode, HN; Xiang, R; Becker, JC; Gillies, SD; Reisfeld, RA Immunocytokines: a promising approach to cancer immunotherapy.
Pharmacol Ther. 1998; 80(3):277-292
Web of Science PubMed

 

Seidel, MG; Freissmuth, M; Pehamberger, H; Micksche, M Stimulation of natural killer activity in peripheral blood lymphocytes of healthy donors and melanoma patients in vitro: synergism between interleukin (IL)-12 and IL-15 or IL-12 and IL-2.
Naunyn Schmiedebergs Arch Pharmacol. 1998; 358(3):382-389
Web of Science PubMed FullText FullText_MUG

 

Trcka, J; Kampgen, E; Becker, JC; Schwaaf, A; Brocker, EB Immunochemotherapy of malignant melanoma. Epifocal administration of dinitrochlorobenzene (DNCB) combined with systemic chemotherapy with dacarbazine (DTIC)
Hautarzt. 1998; 49(1):17-22
Web of Science PubMed

 

Wagner, SN; Schultewolter, T; Wagner, C; Briedigkeit, L; Becker, JC; Kwasnicka, HM; Goos, M Immune response against human primary malignant melanoma: a distinct cytokine mRNA profile associated with spontaneous regression.
Lab Invest. 1998; 78(5):541-550
Web of Science PubMed Google Scholar

 

1995

BROCKER, EB; BECKER, JC Immunology of melanoma
HAUTARZT. 1995; 46(11): 818-828.
Web of Science PubMed Google Scholar

 

Weitere 50 Treffer anzeigen
© Meduni Graz Impressum